| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Sunitinib | FAERS: 2 | US FAERS | |
| 2 | Tolvaptan | FAERS: 2 | US FAERS | |
| 3 | Everolimus | FAERS: 1 | US FAERS | |
| 4 | Hydrochlorothiazide | FAERS: 1 | US FAERS | |
| 5 | Levetiracetam | FAERS: 1 | US FAERS | |
| 6 | Lurasidone Hydrochloride | FAERS: 1 | US FAERS | |
| 7 | Melphalan | FAERS: 1 | US FAERS | |
| 8 | Omeprazole | FAERS: 1 | US FAERS | |
| 9 | Betahistine | OFFSIDES | ||
| 10 | Bezafibrate | OFFSIDES | ||
| 11 | Bortezomib | OFFSIDES | ||
| 12 | Codeine | OFFSIDES | ||
| 13 | Doxycycline | OFFSIDES | ||
| 14 | Glycerol | OFFSIDES | ||
| 15 | Trimetazidine | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120265
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.